Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
microRNA
58%
Warfarin
53%
Diseases
39%
Neoplasm
32%
Chitosan
28%
Diabetes Mellitus
24%
Drug Delivery System
23%
Liver Cell Carcinoma
19%
Untranslated RNA
18%
Polysaccharide
16%
Cross-Sectional Study
15%
Chemotherapy
15%
Hyaluronic Acid
14%
Silymarin
14%
Clopidogrel
13%
Liver Enzyme
13%
Parkinson's Disease
13%
Atherosclerosis
13%
Silibinin
13%
Cisplatin
13%
Doxorubicin
13%
Prostate Cancer
13%
Liposome
13%
Lung Cancer
13%
Astragalus
13%
Nanoparticle
13%
Antioxidant
12%
Combination Therapy
12%
SARS Coronavirus
12%
Cardiovascular Disease
11%
Superoxide Dismutase
11%
Tumor Growth
11%
Nanomaterial
11%
CYP2C9
11%
Biocompatibility
10%
Eye Disease
9%
Breast Cancer
9%
Clinical Pharmacy
9%
Carbon Dioxide
9%
Quercetin
9%
Tumor Microenvironment
9%
Drug Interaction
9%
Clinical Study
9%
Pharmacokinetic
8%
Tablet
8%
Pharmacotherapy
8%
Biopolymer
8%
Controlled Release
8%
High Performance Liquid Chromatography
8%
Medicine and Dentistry
microRNA
43%
Malignant Neoplasm
38%
Cancer Therapy
29%
Programmed Cell Death
24%
Metastatic Carcinoma
22%
Neoplasm
21%
Cancer Cell
18%
Hepatocellular Carcinoma
13%
Exosome
13%
Ophthalmology
13%
Epithelial Mesenchymal Transition
13%
Prostate Cancer
13%
Lung Cancer
13%
Breast Cancer
13%
Cell Death
11%
Tumor Progression
11%
Cancer Inhibition
10%
Autophagy
9%
Systematic Review
9%
Combination Therapy
9%
Angiogenesis
9%
Cardiovascular Disease
8%
Diseases
8%
Oxidative Stress
7%
Cancer
6%
Coronavirinae
6%
Complications of Diabetes Mellitus
6%
Gene Vector
6%
Virus Gene
6%
Subretinal Drug Administration
6%
Public Health
6%
Phase I Trials
6%
Mesenchymal Stem Cell
6%
Gene Therapy
6%
Retinitis pigmentosa
6%
Liver Enzyme
6%
Disinfectant Agent
6%
Restylane
6%
Meta-Analysis
6%
Apigenin
6%
Clinical Trial
6%
Nonalcoholic Fatty Liver
6%
Fatty Liver
6%
Medicine
6%
Glycon
6%
Supplementation
6%
Acute Myeloid Leukemia
6%
Drug Therapy
6%
Chimeric Antigen Receptor T-Cell Immunotherapy
6%
Tertiary Care
6%
Biochemistry, Genetics and Molecular Biology
MicroRNA
28%
Cancer Cell
20%
Social Interaction
15%
Genotyping
13%
CYP2C9
13%
Aptamer
13%
Programmed Cell Death
13%
Vitamin K Epoxide Reductase
10%
Cell Death
8%
Mesenchymal-Epithelial Transition
8%
Autophagy
8%
Tumor Progression
8%
Antimicrobial Activity
7%
Docking (Molecular)
7%
Stem Cell
7%
High-Performance Liquid Chromatography
7%
Anticancer
6%
RNA
6%
Osmoregulation
6%
Mugil cephalus
6%
Phase I Trials
6%
Genetic Risk
6%
Virus Gene
6%
MERTK
6%
Copurification
6%
Gene Vector
6%
Quercetin
6%
Polysaccharide
6%
Antineoplastic Activity
6%
JAK-STAT Signaling
6%
Circular RNA
6%
Retinitis pigmentosa
6%
Patient Compliance
6%
Single Nucleotide Polymorphism
6%
Comorbidity
6%
Gene Polymorphism
6%
Oxidoreductase
6%
Binding Affinity
6%
Reductase
6%
Myeloid
6%
Bovine Serum Albumin
6%
Thiazole
6%
Pharmaceutical Application
6%
Cohort Study
6%
Indel
6%
Angiotensin-Converting Enzyme
6%
Cross Sectional Study
6%
Antiinflammatory Activity
6%
Allele
6%
Isoform
5%
